div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: crizotlnlb-atentionari insuficienta · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut src=https:reader033fdocumentecomreader033viewer20220414165e1bb2dc6221a0063c0b94fbhtml5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: crizotlnlb-atentionari insuficienta · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut src=https:reader033fdocumentecomreader033viewer20220414165e1bb2dc6221a0063c0b94fbhtml5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: crizotlnlb-atentionari insuficienta · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut src=https:reader033fdocumentecomreader033viewer20220414165e1bb2dc6221a0063c0b94fbhtml5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: crizotlnlb-atentionari insuficienta · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut src=https:reader033fdocumentecomreader033viewer20220414165e1bb2dc6221a0063c0b94fbhtml5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdiv